$OPCH
Option Care Health, Inc.

2024 Q4 Form 10-Q Financial Statement

#000101473924000052 Filed on October 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.279B
YoY Change 16.97%
Cost Of Revenue $1.022B
YoY Change 21.82%
Gross Profit $256.7M
YoY Change 0.98%
Gross Profit Margin 20.08%
Selling, General & Admin $157.0M
YoY Change -0.77%
% of Gross Profit 61.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.66M
YoY Change -2.31%
% of Gross Profit 5.71%
Operating Expenses $171.7M
YoY Change -0.9%
Operating Profit $85.09M
YoY Change 4.99%
Interest Expense $12.35M
YoY Change 4.74%
% of Operating Profit 14.51%
Other Income/Expense, Net -$583.0K
YoY Change 29.84%
Pretax Income $73.55M
YoY Change 4.95%
Income Tax $19.70M
% Of Pretax Income 26.78%
Net Earnings $53.86M
YoY Change -4.34%
Net Earnings / Revenue 4.21%
Basic Earnings Per Share $0.32
Diluted Earnings Per Share $0.31
COMMON SHARES
Basic Shares Outstanding 170.2M shares 171.0M shares
Diluted Shares Outstanding 171.9M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $483.0M
YoY Change 24.97%
Cash & Equivalents $483.0M
Short-Term Investments
Other Short-Term Assets $98.80M
YoY Change 3.45%
Inventory $310.6M
Prepaid Expenses
Receivables $429.0M
Other Receivables $0.00
Total Short-Term Assets $1.321B
YoY Change 18.37%
LONG-TERM ASSETS
Property, Plant & Equipment $125.9M
YoY Change 16.63%
Goodwill $1.540B
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $23.60M
YoY Change 21.03%
Other Assets $41.38M
YoY Change -19.49%
Total Long-Term Assets $2.106B
YoY Change -0.99%
TOTAL ASSETS
Total Short-Term Assets $1.321B
Total Long-Term Assets $2.106B
Total Assets $3.428B
YoY Change 5.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $592.0M
YoY Change 37.82%
Accrued Expenses $164.7M
YoY Change -12.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $6.512M
YoY Change 8.53%
Total Short-Term Liabilities $763.2M
YoY Change 22.3%
LONG-TERM LIABILITIES
Long-Term Debt $1.105B
YoY Change 4.55%
Other Long-Term Liabilities $279.0K
YoY Change -90.97%
Total Long-Term Liabilities $1.238B
YoY Change 4.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $763.2M
Total Long-Term Liabilities $1.238B
Total Liabilities $2.001B
YoY Change 10.98%
SHAREHOLDERS EQUITY
Retained Earnings $609.2M
YoY Change 52.17%
Common Stock $1.224B
YoY Change 2.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.426B
YoY Change
Total Liabilities & Shareholders Equity $3.428B
YoY Change 5.68%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $53.86M
YoY Change -4.34%
Depreciation, Depletion And Amortization $14.66M
YoY Change -2.31%
Cash From Operating Activities $160.4M
YoY Change 162.95%
INVESTING ACTIVITIES
Capital Expenditures $9.669M
YoY Change 15.11%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$9.669M
YoY Change -32.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -44.58M
YoY Change -56.04%
NET CHANGE
Cash From Operating Activities 160.4M
Cash From Investing Activities -9.669M
Cash From Financing Activities -44.58M
Net Change In Cash 106.2M
YoY Change -294.07%
FREE CASH FLOW
Cash From Operating Activities $160.4M
Capital Expenditures $9.669M
Free Cash Flow $150.7M
YoY Change 186.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001014739
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
OPTION CARE HEALTH, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
05-0489664
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300N,
dei Entity Address City Or Town
EntityAddressCityOrTown
Bannockburn,
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60015
dei Local Phone Number
LocalPhoneNumber
940-2443
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
OPCH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
170181238 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
483026000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
343849000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
428951000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
377658000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
310599000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
274004000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
98798000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
98744000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1321374000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1094255000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
125911000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120630000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
89210000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
84159000 usd
CY2024Q3 bios Finite Lived Intangible Assets Net Excluding Customer Lists
FiniteLivedIntangibleAssetsNetExcludingCustomerLists
17768000 usd
CY2023Q4 bios Finite Lived Intangible Assets Net Excluding Customer Lists
FiniteLivedIntangibleAssetsNetExcludingCustomerLists
20092000 usd
CY2023Q4 bios Finite Lived Customer Lists Net
FiniteLivedCustomerListsNet
315304000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41379000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42349000 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
2106353000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2122780000 usd
CY2024Q3 us-gaap Assets
Assets
3427727000 usd
CY2023Q4 us-gaap Assets
Assets
3217035000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
591971000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
426513000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
60835000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
92508000 usd
CY2024Q3 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
81893000 usd
CY2023Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
75010000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
22013000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18278000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6512000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
763224000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
618309000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1105106000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1056650000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87879000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
85484000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
45008000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
34920000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
279000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1238272000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1795363000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
183793536 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
170146331 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
182905559 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
174575537 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
18000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
18000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
13647205 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
8330022 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
416552000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
255107000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1204270000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
457513000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9503000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
14978000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1426231000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3427727000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3651784000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3177934000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2907170000 usd
us-gaap Operating Expenses
OperatingExpenses
504061000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
85091000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
81047000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
234796000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
230039000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
12345000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
11786000 usd
us-gaap Interest Expense
InterestExpense
38150000 usd
us-gaap Interest Expense
InterestExpense
38816000 usd
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1391000 usd
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1273000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
3921000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
4107000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-583000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84487000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-5475000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-99000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6127000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
53000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5475000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-99000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47729000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
56355000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
146215000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
209814000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.17
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170636000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
178826000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172490000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179956000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171941000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180528000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173848000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181286000 shares
us-gaap Net Income Loss
NetIncomeLoss
151690000 usd
us-gaap Net Income Loss
NetIncomeLoss
209913000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
46029000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
46423000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17892000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
14610000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10088000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11767000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1133244000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5885000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
15741000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1111618000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6512000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1105106000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
1540246000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1540246000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1177054000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2001496000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1224059000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
609203000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1421672000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3217035000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1278546000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1093014000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1021797000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
838748000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2443834000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
256749000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
254266000 usd
us-gaap Gross Profit
GrossProfit
744614000 usd
us-gaap Gross Profit
GrossProfit
734100000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
158214000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
465524000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
459644000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15005000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44294000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44417000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
171658000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
173219000 usd
us-gaap Operating Expenses
OperatingExpenses
509818000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1983000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-11537000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10962000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-32246000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
49778000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73554000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70085000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
202550000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
279817000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19698000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13783000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50860000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
56302000 usd
us-gaap Net Income Loss
NetIncomeLoss
151690000 usd
us-gaap Net Income Loss
NetIncomeLoss
209913000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-1998000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-8000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-1785000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-57000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-6127000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
53000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
4756000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
4500000 usd
us-gaap Net Income Loss
NetIncomeLoss
151690000 usd
us-gaap Net Income Loss
NetIncomeLoss
209913000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
178826000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172490000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179956000 shares
dei Entity File Number
EntityFileNumber
001-11993
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
51293000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5075000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36595000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28362000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3197000 usd
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
156999000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-449000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69904000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
53856000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-377000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3465000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3312000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3921000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4107000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
27620000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
22908000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1250000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4000000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1769000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3175000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
164754000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
50726000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-31673000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
5560000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
9829000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
16833000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
13019000 usd
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
11762000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
287270000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
320326000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25266000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21981000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12855000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
343849000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
294186000 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
3000 Lakeside Dr.
dei City Area Code
CityAreaCode
312
CY2024Q3 bios Finite Lived Customer Lists Net
FiniteLivedCustomerListsNet
291839000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14659000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1845000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4197000 usd
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-3880000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5889000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25266000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40725000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11235000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1940000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
49959000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
77000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
160122000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
175108000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3404000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5750000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-122827000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-187298000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
139177000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
92303000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
483026000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
386489000 usd
us-gaap Interest Paid Net
InterestPaidNet
48666000 usd
us-gaap Interest Paid Net
InterestPaidNet
46377000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
45258000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
53699000 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
21861000 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
20272000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1386103000 usd
CY2023Q1 bios Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings
StockIssuedValueRestrictedStockStockOptionsExercisedAndTaxWithholdings
1902000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5988000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75735000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
39208000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3443000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1350219000 usd
CY2023Q2 bios Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings
StockIssuedValueRestrictedStockStockOptionsExercisedAndTaxWithholdings
247000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7685000 usd
CY2023Q2 bios Stock Repurchased During Period Value Including Related Tax Effects
StockRepurchasedDuringPeriodValueIncludingRelatedTaxEffects
-32000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
114403000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3291000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1475383000 usd
CY2023Q3 bios Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings
StockIssuedValueRestrictedStockStockOptionsExercisedAndTaxWithholdings
-209000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9235000 usd
CY2023Q3 bios Stock Repurchased During Period Value Including Related Tax Effects
StockRepurchasedDuringPeriodValueIncludingRelatedTaxEffects
101099000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
56302000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
53000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1440083000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1421672000 usd
CY2024Q1 bios Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings
StockIssuedValueRestrictedStockStockOptionsExercisedAndTaxWithholdings
8182000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9605000 usd
CY2024Q1 bios Stock Repurchased During Period Value Including Related Tax Effects
StockRepurchasedDuringPeriodValueIncludingRelatedTaxEffects
40289000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
44791000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1551000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1429148000 usd
CY2024Q2 bios Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings
StockIssuedValueRestrictedStockStockOptionsExercisedAndTaxWithholdings
-1299000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7608000 usd
CY2024Q2 bios Stock Repurchased During Period Value Including Related Tax Effects
StockRepurchasedDuringPeriodValueIncludingRelatedTaxEffects
78768000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
53043000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-899000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1411431000 usd
CY2024Q3 bios Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings
StockIssuedValueRestrictedStockStockOptionsExercisedAndTaxWithholdings
948000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10407000 usd
CY2024Q3 bios Stock Repurchased During Period Value Including Related Tax Effects
StockRepurchasedDuringPeriodValueIncludingRelatedTaxEffects
42388000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
53856000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6127000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1426231000 usd
CY2024Q3 bios Number Of Service Locations
NumberOfServiceLocations
92 pharmacy
CY2024Q3 bios Number Of Infusion Sites
NumberOfInfusionSites
93 suite
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
45900000 usd
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
52000000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
23600000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
20900000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1400000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3900000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1300000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4100000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1278546000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1093014000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3651784000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3177934000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50900000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69900000 usd
bios Termination Fee Income Tax Effect
TerminationFeeIncomeTaxEffect
22100000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.197
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.197
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.197
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50900000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69900000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
53856000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
56302000 usd
us-gaap Net Income Loss
NetIncomeLoss
151690000 usd
us-gaap Net Income Loss
NetIncomeLoss
209913000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170636000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
178826000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172490000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179956000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.17
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
53856000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
56302000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170636000 shares
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1305000 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1702000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1358000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1330000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171941000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180528000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173848000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181286000 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
8600000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
25300000 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
7800000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
22300000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y6M
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0649
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7464000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
28646000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
25880000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20554000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13517000 usd
CY2024Q3 bios Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
43813000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
139874000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
29982000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
109892000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
23000000.0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
26100000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
262947000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
244501000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
137036000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
123871000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
125911000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120630000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
6631000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
6981000 usd
us-gaap Depreciation
Depreciation
20220000 usd
us-gaap Depreciation
Depreciation
20671000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
554509000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
554519000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
244902000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
219123000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
309607000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
335396000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8600000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25800000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8600000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25600000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1088000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6974000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
18376000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1062650000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1056650000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1628000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6512000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6512000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6512000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
612080000 usd
CY2024Q3 bios Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
500000000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1133244000 usd
CY2024Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1111618000 usd
CY2024Q3 us-gaap Derivative Assets
DerivativeAssets
12669000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
19929000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
13101734 shares
CY2024Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1399674 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5317183 shares
CY2024Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
29.97
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
30.09
CY2024Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
41900000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
160000000.0 usd
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2913520 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5388686 shares
CY2023Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
34.32
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
32.48
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
100000000.0 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
175000000.0 usd
CY2024Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
90000000.0 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
bios-20240930_cal.xml Edgar Link unprocessable
0001014739-24-000052-index-headers.html Edgar Link pending
0001014739-24-000052-index.html Edgar Link pending
0001014739-24-000052.txt Edgar Link pending
0001014739-24-000052-xbrl.zip Edgar Link pending
bios-20240930.htm Edgar Link pending
bios-20240930.xsd Edgar Link pending
bios-20240930_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
opch-ex311x2024093010xq.htm Edgar Link pending
opch-ex312x2024093010xq.htm Edgar Link pending
opch-ex321x2024093010xq.htm Edgar Link pending
opch-ex322x2024093010xq.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
bios-20240930_def.xml Edgar Link unprocessable
bios-20240930_lab.xml Edgar Link unprocessable
bios-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bios-20240930_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending